Tara Abraham
Obstetrics & Gynecology · Wahington, DCNPI 1396035580
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $310 and has fallen 54.5% since, to $141 in 2025.
Across 55 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$237
- Pfizer$187
- Astellas Pharma Global Development$118
- Hologic Sales And Service, LLC$114
- Astellas Pharma US Inc$96
- Sumitomo Pharma America, Inc.$93
- plus $403 from 16 others
What the payments were for
- Food & beverage$1,23199%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $237 |
| Pfizer | 11 | $187 |
| Astellas Pharma Global Development | 1 | $118 |
| Hologic Sales And Service, LLC | 3 | $114 |
| Astellas Pharma US Inc | 5 | $96 |
| Sumitomo Pharma America, Inc. | 4 | $93 |
| Johnson & Johnson | 1 | $79 |
| Bayer | 2 | $42 |
| Aesculap, Inc. | 1 | $35 |
| BD | 2 | $33 |
| Myovant Sciences Inc. | 1 | $25 |
| Sage Therapeutics, LLC | 1 | $24 |
| Therapeuticsmd, Inc. | 1 | $24 |
| Biogen | 1 | $19 |
| Millicent US Inc | 1 | $19 |
| Merck | 1 | $17 |
| Aspira Women's Health Inc | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Coopersurgical, Inc. | 1 | $16 |
| Minerva Surgical, Inc | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$118
How this compares
$1,248 in reported general payments places this provider in the 75th percentile of 195 obstetrics & gynecology providers in District of Columbia.
See all obstetrics & gynecology providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 32 | $3,322 |
| Alendronate Sodium | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Wahington
- Mark HathawayWashington$180K
- Renuka Darolia AdelizziWashington$72K
- Jovana TavcarWashington$5K
- Rachel ScottWashington$5K
- Jamila PerrittWashington$5K
- Stephanie HackWashington$4K
- Nicholas HazenWashington$4K
- Serina FloydWashington$4K
- Amr MadkourWashington$4K
- Peng YeWashington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.